Unknown

Dataset Information

Extracellular vesicle surface display enhances the therapeutic efficacy and safety profile of cancer immunotherapy.


ABSTRACT: Immunotherapy has emerged as a mainstay in cancer therapy, yet its efficacy is constrained by the risk of immune-related adverse events. In this study, we present a nanoparticle-based delivery system that enhances the therapeutic efficacy of immunomodulatory ligands while concurrently limiting systemic toxicity. We demonstrate that extracellular vesicles (EVs), lipid bilayer enclosed particles released by cells, can be efficiently engineered via inverse electron demand Diels-Alder (iEDDA)-mediated conjugation to display multiple immunomodulatory ligands on their surface. Display of immunomodulatory ligands on the EV surface conferred substantial enhancements in signaling efficacy, particularly for tumor necrosis factor receptor superfamily (TNFRSF) agonists, where the EV surface display se

SUBMITTER: Jayasinghe MK 

PROVIDER: S-EPMC11489549 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature